As maddening as nonrestorative sleep night after night can be, the consequences go much deeper. Left unaddressed, sleep apnea ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...
MindBio Therapeutics obtained approvals for clinical trials in women’s health using its proprietary LSD drug, MB22001. MB22001 aims to address a huge unmet need in the ~25% of women who experience PMS ...